NCT00115427View on ClinicalTrials.gov

Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2003

Conditions
Idiopathic Parkinson's Disease
Interventions
DRUG

Liatermin (r-metHuGDNF)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY